Characterization of the interaction between endostatin short peptide and VEGF receptor 3

Protein and Peptide Letters

Volumn 19, Issue 9, 2012, Pages 969-974

  Han, Kyu Yeon ^a   Azar, Dimitri T ^a   Sabri, Abdellah ^a   Lee, Hyun ^b   Jain, Sandeep ^a   Lee, Bao Shiang ^c   Chang, Jin Hong ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b 203 Pharmacy Building   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Endostatin; Lymphangiogenesis; Peptide fragment; Surface plasmon resonance; VEGF; VEGFR

Indexed keywords

ALANINE; AMINO ACID; CYSTEINE; ENDOSTATIN; FIBROBLAST GROWTH FACTOR 2; PEPTIDE; RECOMBINANT RECEPTOR; VASCULOTROPIN; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DRUG RECEPTOR BINDING; GRAFT REJECTION; HUMAN; HUMAN CELL; LYMPHANGIOGENESIS; LYMPHEDEMA; METASTASIS; PROTEIN SECONDARY STRUCTURE; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE;

AMINO ACID SEQUENCE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CONSERVED SEQUENCE; CYSTEINE; ENDOSTATINS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDES; SEQUENCE ALIGNMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 84865724017     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986612802084465     Document Type: Article

References (21)

1. O'Reilly, M.S.; Boehm, T.; Shing, Y.; Fukai, N.; Vasios, G.; Lane, W.S.; Flynn, E.; Birkhead, J.R.; Olsen, B.R.; Folkman, J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997, 88, 277-85.
2. Veillard, F.; Saidi, A.; Burden, R.E.; Scott, C.J.; Gillet, L.; Lecaille, F.; Lalmanach, G. Cysteine cathepsins S and L modulate anti-angiogenic activities of human endostatin. J. Biol. Chem., 2011, 286, 37158-67.
3. Becker, C.M.; Sampson, D.A.; Short, S.M.; Javaherian, K.; Folkman, J.; D'Amato, R.J. Short synthetic endostatin peptides inhibit endothelial migration in vitro and endometriosis in a mouse model. Fertil Steril., 2006, 85, 71-7.
4. A. Abdollahi, A.; Hahnfeldt, P.; Maercker, C.; Gröne, H.J.; Debus, J.; Ansorge, W.; Folkman, J.; Hlatky, L.; Huber, P.E. Endostatin's antiangiogenic signaling network. Mol. Cell, 2004, 13, 649-63.
5. Faye, C.; Moreau, C.; Chautard, E.; Jetne, R.; Fukai, N.; Ruggiero, F.; Humphries, M.J.; Olsen, B.R.; Ricard-Blum, S. Molecular interplay between endostatin, integrins, and heparan sulfate. J. Biol. Chem., 2009, 284, 22029-40.
6. Rehn, M.; Veikkola, T.; Kukk-Valdre, E.; Nakamura, H.; Ilmonen, M.; Lombardo, C.; Pihlajaniemi, T.; Alitalo, K.; Vuori, K. Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. USA, 2001, 98, 1024-9.
7. Kim, Y.M.; Hwang, S.; Kim, Y.M.; Pyun, B.J.; Kim, T.Y.; Lee, S.T.; Gho, Y.S.; Kwon, Y.G. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J. Biol. Chem., 2002, 277, 27872-9.
8. Kojima, T.; Azar, D.T.; Chang, J.H. Neostatin-7 regulates bFGF-induced corneal lymphangiogenesis. FEBS Lett., 2008, 582, 2515-20.
9. Karihalo, A.; Karumanchi, S.A.; Barasch, J.; Jha, V.; Nickel, C.H.; Yang, J.; Grisaru, S.; Bush, K.T.; Nigam, S.; Rosenblum, N.D.; Sukhatme, V.P.; Cantley, L.G. Endostatin regulates branching morphogenesis of renal epithelial cells and ureteric bud. Proc. Natl. Acad. Sci. USA, 2001, 98, 12509-14.
10. Xu, H.L.; Tan, H.N.; Wang, F.S.; Tang, W. Research advances of endostatin and its short internal fragments. Curr. Protein Pept. Sci., 2008, 9, 275-83.
11. McKern, N.M.; Edskes, H.K.; Shukla, D.D. Purification of hydrophilic and hydrophobic peptide fragments on a single reversed phase high performance liquid chromatographic column. Biomed. Chromatogr., 1993, 7, 15-9.
12. Pytowski, B.; Goldman, J.; Persaud, K.; Wu, Y.; Witte, L.; Hicklin, D.J.; Skobe, M.; Boardman, K.C.; Swartz, M.A. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J. Natl. Cancer Inst., 2005, 97, 14-21.
13. Leppänen, V.M.; Prota, A.E.; Jeltsch, M.; Anisimov, A.; Kalkkinen, N.; Strandin, T.; Lankinen, H.; Goldman, A.; Ballmer-Hofer, K.; Alitalo, K. Structural determinants of growth factor binding and specificity by VEGF receptor 2. Proc. Natl. Acad. Sci. USA, 2010, 107, 2425-30.
14. Yang, Y.; Xie, P.; Opatowsky, Y.; Schlessinger, J. Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signaling. Proc. Natl. Acad. Sci. USA, 2010, 107, 1906-11.
15. Tjin Tham Sjin, R.M.; Satchi-Fainaro, R.; Birsner, A.E.; Ramanujam, V.M.; Folkman, J.; Javaherian, K. A 27-amino-acid synthetic peptide corresponding to the NH2-terminal zinc-binding domain of endostatin is responsible for its antitumor activity. Cancer Res., 2005, 65, 3656-63.
16. Yamaguchi, N.; Anand-Apte, B.; Lee, M.; Sasaki, T.; Fukai, N.; Shapiro, R.; Que, I.; Lowik, C.; Timpl, R.; Olsen, B.R. Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. Embo. J.,1999, 18, 4414-23.
17. Boehm, T.; O'Reilly, M.S.; Keough, K.; Shiloach, J.; Shapiro, R.; Folkman, J. Zinc-binding of endostatin is essential for its antiangio-genic activity. Biochem. Biophys. Res. Commun., 1998, 252, 190-4.
18. Cattaneo, M.G.; Pola, S.; Francescato, P.; Chillemi, F.; Vicentini, L.M. Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo. Exp. Cell Res., 2003, 283, 230-6.
19. Zhang, H.T.; Li, H.C.; Li, Z.W.; Guo, C.H.; Chen, Y.J. An RGD-Modified Endostatin Peptide Expressed at E. coli Shows Anti-Tumor Activity In vivo. Protein Pept. Lett., 2011, 79(9), 2684-92
20. Ou, J.; Li, J.; Pan, F.; Xie, G.; Zhou, Q.; Huang, H.; Liang, H. Endostatin suppresses colorectal tumor-induced lymphangiogenesis by inhibiting expression of fibronectin extra domain A and integrin alpha9. J. Cell Biochem., 2011, 112, 2106-14.
21. Jeltsch, M.; Karpanen, T.; Strandin, T.; Aho, K.; Lankinen, H.; Alitalo, K. Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns. J. Biol. Chem., 2006, 281, 12187-95.